NOTES-Assisted Laparoscopic Cholecystectomy Surgery

Sponsor
USGI Medical (Industry)
Overall Status
Terminated
CT.gov ID
NCT00486655
Collaborator
(none)
25
1
1
24.5

Study Details

Study Description

Brief Summary

This study proposes to evaluate the ability to reduce the size and number of laparoscopic incisions required to perform gall bladder removal by using flexible endoscopic instruments introduced through the mouth, into the stomach and through the stomach wall.

Condition or Disease Intervention/Treatment Phase
  • Procedure: NOTES-Assisted Cholecystectomy
N/A

Detailed Description

A typical laparoscopic gall bladder removal procedure requires placement of a rigid laparoscope through a 1.5-2.5 cm incision in the umbilicus and then 2-3 additional 0.5 cm incisions for additional instrumentation. While post-operative complication rates for this procedure are small, wound infection, particularly of the large incision, is one of the most common post-operative complications. There is also a risk of a post-operative hernia at these incision sites.

A less invasive surgical technique that reduces the size or number of laparoscopic incisions offers the potential clinical benefits of eliminating wound infections, hernias and decreasing post-operative pain following laparoscopic gall bladder removal.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
25 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Assisted Laparoscopic Cholecystectomy Surgery
Study Start Date :
May 1, 2007
Actual Study Completion Date :
Jun 1, 2007

Outcome Measures

Primary Outcome Measures

  1. Quality of Life [2 weeks]

Secondary Outcome Measures

  1. Incidence of complications [2 weeks]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 85 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Ability to undergo general anesthesia

  • Age >= 18 yrs. of age and <= 85 yrs. of age

  • Ability to give informed consent

Exclusion Criteria:
  • Acute cholecystitis

  • BMI >= 40

  • Contraindicated for EGD

  • Presence of common duct stones

  • Presence of esophageal stricture

  • Altered gastric anatomy

Contacts and Locations

Locations

Site City State Country Postal Code
1 Oregon Clinic Portland Oregon United States 97210

Sponsors and Collaborators

  • USGI Medical

Investigators

  • Principal Investigator: Lee Swanstrom, MD, Oregon Clinic

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00486655
Other Study ID Numbers:
  • LS0701
First Posted:
Jun 14, 2007
Last Update Posted:
Aug 8, 2012
Last Verified:
Aug 1, 2012
Keywords provided by , ,
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 8, 2012